Tech Company M&A Transactions
Lutonix Acquisition
On 12/20/2011, Lutonix was bought by C.R. Bard. The transaction price was $325 million.
Transaction Overview
Company Name
Acquired By
Announced On
12/20/2011
Transaction Type
M&A
Amount
$325,000,000
M&A Terms
C. R. Bard, Inc. (NYSE: BCR) today announced that it has acquired Lutonix, Inc. for a purchase price of approximately $225 million paid at closing, with an additional $100 million to be paid upon PMA approval of Lutonix's drug-coated percutaneous transluminal angioplasty (PTA) balloon. The transaction is structured as a merger.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
7351 Kirkwood Lane North 138
Maple Grove, MN 55369
USA
Maple Grove, MN 55369
USA
Phone
Website
Email Address
Overview
The Vision of Lutonix is to improve the quality of life for patients with vascular disease through innovative solutions.The Mission of Lutonix is to rapidly develop and commercialize the safest and most efficacious drug coated balloon catheters for treatment of vascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Wahr
Chief Scientific Officer
Scott Naisbitt
Chief Technical Officer
Lixiao Wang
VP - Finance
Kari Kubesh
VP - R & D
Chris Barry
VP - Regulatory Affairs
Debra Lano
Browse more venture capital transactions:
Prev: 12/20/2011: Appconomy venture capital transaction
Next: 12/20/2011: LensAR venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs